About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Kidney Disease Clinical Trials in Chicago | 134 Studies

Clinical Trials Kidney DiseaseChicago

Kidney Disease Clinical Trials in Chicago

Find 134 clinical trials for kidney disease near Chicago, Illinois. Connect with research centers in your area.

All Kidney Disease trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 134 trials

CompletedA Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney DiseaseThis study is open to adults with chronic kidney disease. People with and without type 2 diabetes can take part in this study.NCT05182840·Mesa, Arizona and 202 others

Kidney Disease Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTreatment of Autonomous Hyperparathyroidism in Post Renal Transplant RecipientsHyperparathyroidism (HPT) is common in people with a kidney transplant.NCT00975000·Phoenix, Arizona and 50 others

CompletedAnemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)The purpose of this multi-center study is to evaluate the efficacy and safety of daprodustat in subjects with anemia associated with CKD.NCT03029208·Anaheim, California and 110 others

CompletedResistance Exercise Training in Chronic Kidney DiseaseThe investigators aim to evaluate the feasibility of a resistance exercise training program among individuals with CKD and its impact on endothelial and vascular function.NCT03120416·Chicago, Illinois

RecruitingA Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study designed to evaluate the efficacy and safety of praliciguat in adults with biopsy-confirmed…NCT07268638·Chula Vista, California and 24 others

CompletedSafety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney…NCT00048438·Orange, California and 17 others

CompletedThe BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR)The two doses of sodium bicarbonate being tested are 0.5 and 0.8 mEq/kg-lean body weight (LBW) per day.NCT02521181·Denver, Colorado and 6 others

TerminatedEmpowering Veterans to Communicate With Healthcare ProvidersThe goal of this VA Innovation Seed project is to test the best approach for the delivery, feasibility, and usability of a patient-centered CKD-QPS to facilitate better Veteran…NCT03529071·Chicago, Illinois and 1 other

UnknownThe Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell AnemiaThis is a multicenter prospective, longitudinal cohort study which will evaluate the predictive capacity of machine learning (ML) models for progression of CKD in eligible…NCT05214105·Chicago, Illinois and 2 others

Active not recruitingAn Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney DiseaseRESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time.NCT06754280·Chicago, Illinois

CompletedThe Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) StudyThe primary hypothesis is that titration of ACE inhibitor and Angiotensin Receptor Blockers (ARBs)to reduce urine protein excretion to \< 500 mg per day in Fabry Patients…NCT00446862·Birmingham, Alabama and 5 others

TerminatedSafety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on DialysisPrimary Objective: Evaluated the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).NCT02859896·Birmingham, Alabama and 22 others

CompletedThe Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System InhibitorsThe study objective was to evaluate the safety of paricalcitol capsules and the efficacy of paricalcitol capsules for albuminuria reduction in patients with Chronic Kidney Disease…NCT00421733·Phoenix, Arizona and 71 others

CompletedIdentification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD PatientsThe purpose of this study is to identify genes that are responsive to paricalcitol (active vitamin D) therapy.NCT02018133·Chicago, Illinois

RecruitingInteractive Computer-adaptive Chronic Kidney Disease Education ProgramThe goal of this pilot clinical trial is to evaluate a culturally tailored computerized education program in hospitalized African-American patients with advanced chronic kidney…NCT06364358·Chicago, Illinois

CompletedTrial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 InhibitionPatients with chronic kidney disease, who have evidence of systemic inflammation with increased cardiovascular risk, will be enrolled into this trial.NCT03926117·Birmingham, Alabama and 48 others

CompletedA Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With NephropathyProspective, Randomized, Double-Blind, Parallel Design, Placebo-Controlled Multicenter Study.NCT01399580·Phoenix, Arizona and 27 others

CompletedA Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinThe purpose of this study is to demonstrate therapeutic equivalence of subcutaneous (SC) Epoetin Hospira compared to SC Epogen (Amgen), based on maintenance of hemoglobin (Hb)…NCT01473420·Azusa, California and 72 others

CompletedStudy to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney DiseaseA multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in participants with Non-Dialysis-Dependent…NCT02648347·Huntsville, Alabama and 438 others

CompletedSleep Disturbances as a Risk Factor in Chronic Kidney DiseaseThis study is designed to determine if either short night time sleep or poor night time sleep could be a risk factor for increasing the rate at which kidney function deteriorates…NCT00817427·Chicago, Illinois

Page 1 of 7Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia